Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

T Regulatory Cells, The Next T Cell Frontier?

Posted By Randy Alfano Ph.D. on 5/28/19 8:09 AM

Recently I had the opportunity to attend the Treg Summit in Boston to listen to the ground-breaking clinical and preclinical research in re-balancing the immune system in the context of autoimmunity and organ transplant via the use of polyclonal or antigen-induced T regulatory cells. Overall, this cell therapy holds immense promise as evidenced by both preclinical models and early clinical evaluations.

Read More

Cellastim S Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Posted By Jeanne McAdara Ph.D. on 5/9/19 11:00 AM

The number and breadth of applications for induced human embryonic and pluripotent stem cells (hi-ESCs and hi-PSCs) in both research and clinical settings continue to co-evolve with our understanding of how to harness them as biological tools.

Read More

BIO 2018: The Emergence of Gene & Cell Therapy

Posted By Scott Deeter on 6/11/18 11:10 AM

Last week InVitria attended and celebrated the 25th anniversary of the Biotechnology Industry Organization (BIO) at their annual conference. More than 18,000 delegates over 7,000 companies flew in from around the world and joined InVitria at this event in Boston. A few highlights that emerged from the BIO 2018 conference include: 

Read More